Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—
−0.0130 EUR
−93.15 M EUR
0.00 EUR
6.29 B
About IMUGENE LIMITED
Sector
Industry
CEO
Leslie Chong
Website
Headquarters
Sydney
Founded
1986
ISIN
AU000000IMU9
FIGI
BBG000QBRR16
Imugene Ltd. is a biopharmaceutical company, which engages in the research, development, and commercialization of immunotherapies against cancer. Its products include b-cell peptide cancer vaccines, arginine modulators, and mimotopes. The company was founded on May 30, 1986 and is headquartered in Sydney, Australia.
An aggregate view of professional's ratings.
Displays a symbol's price movements over previous years to identify recurring trends.
Frequently Asked Questions
Depending on the exchange, the stock ticker may vary. For instance, on FWB exchange IMUGENE LTD. stocks are traded under the ticker ILA.
We've gathered analysts' opinions on IMUGENE LTD. future price: according to them, ILA price has a max estimate of 0.26 EUR and a min estimate of 0.06 EUR. Watch ILA chart and read a more detailed IMUGENE LTD. stock forecast: see what analysts think of IMUGENE LTD. and suggest that you do with its stocks.
Yes, you can track IMUGENE LTD. financials in yearly and quarterly reports right on TradingView.
IMUGENE LTD. is going to release the next earnings report on Feb 26, 2025. Keep track of upcoming events with our Earnings Calendar.
ILA earnings for the last half-year are −0.01 EUR per share, whereas the estimation was −0.01 EUR, resulting in a 0.00% surprise. The estimated earnings for the next half-year are −0.01 EUR per share. See more details about IMUGENE LTD. earnings.
IMUGENE LTD. revenue for the last half-year amounts to −964.63 K EUR, despite the estimated figure of 0.00 EUR. In the next half-year revenue is expected to reach 2.18 M EUR.
ILA net income for the last half-year is −50.39 M EUR, while the previous report showed −42.38 M EUR of net income which accounts for −18.89% change. Track more IMUGENE LTD. financial stats to get the full picture.
No, ILA doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
Like other stocks, ILA shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade IMUGENE LTD. stock right from TradingView charts — choose your broker and connect to your account.